Insights Into Renal Cell Carcinoma (RCC) 2022
Perspectives on drivers in treatment decisions in the management of RCC
Faculty Chair
Daniel J. George, MD
Duke Cancer Center, Durham, NC, USA
Faculty Chair
Ulka Vaishampayan, MBBS
Karmanos Cancer Center, Detroit, MI, USA
Faculty Chair
Rana McKay, MD
UC San Diego Medical Center, San Diego, CA, USA
Faculty Chair
Tian Zhang, MD
Duke Cancer Center, Durham, NC, USA
Faculty Chair
Tian Zhang, MD
Duke Cancer Center, Durham, NC, USA
Faculty Chair
Stephanie Berg, MD
Loyola University Medical Center, Maywood, IL, USA
Faculty Chair
Sumanta Pal, MD
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Faculty Chair
David Braun, MD, PhD
Dana-Farber Cancer Center, Boston, MA, USA
Faculty Chair
Ulka Vaishampayan, MBBS
Karmanos Cancer Center, Detroit, MI, USA
Faculty Chair
Daniel J. George, MD
Duke Cancer Center, Durham, NC, USA
Faculty Chair
Daniel J. George, MD
Duke Cancer Center, Durham, NC, USA
Faculty Chair
Asim Bilen, MD
Winship Cancer Institute, Atlanta, GA, USA
Faculty Chair
Alan Tan, MD
Rush University Medical Center, Chicago, IL, USA
Faculty Chair
Ulka Vaishampayan, MBBS
Karmanos Cancer Center, Detroit, MI, USA
Faculty Chair
Gautam Jha, MD
Masonic Cancer Clinic, Minneapolis, MN, USA
Faculty Chair
Ulka Vaishampayan, MBBS
Karmanos Cancer Center, Detroit, MI, USA
Faculty Chair
Elizabeth Wulff-Burchfield, MD
University of Kansas Medical Center, Kansas City, KS, USA
More Information
- Virtual series
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Virtual series
- Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Virtual series
- National
More Information
- Virtual series
- Colorado, Iowa, Oregon
More Information
- Virtual series
- California, Arizona, Nevada, and New Mexico
More Information
- Virtual series
- Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Virtual series
- Minnesota, Illinois
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Virtual series
- Midwest region
More Information
- Virtual series
- Great Lakes
More Information
- Virtual series
- Illinois, Iowa, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio
More Information
- Virtual series
- Great Lakes
More Information
- Virtual series
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of RCC
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: sunitinib, pazopanib, cabozantinib, axitinib, lenvatinib, ipilimumab, pembrolizumab, nivolumab, avelumab, everolimus, and combinations of these drugs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region